The Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024.
- Revenue
- +3.01%
- EPS
- +223.8%
- Free cash flow
- −12.5%
- Total debt
- −7.64%
Quarter to September 2026, against a year earlier
Follow CC
Alert me
The Chemours Company (CC) Net income
The Chemours Company's net income for fiscal 2025 was −$386.0M, compared with $69.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$154.0M. Over the past ten years it has ranged from −$386.0M (fiscal 2025) to $996.0M (fiscal 2018) — the current reading is the lowest in ten years. The Chemours Company ranks 58th of 60 Specialty Chemicals companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$386.0M | — |
| FY2024 | $69.0M | — |
| FY2023 | −$252.0M | — |
| FY2022 | $578.0M | (4.93%) |
| FY2021 | $608.0M | 177.63% |
| FY2020 | $219.0M | — |
| FY2019 | −$52.0M | — |
| FY2018 | $996.0M | 33.33% |
| FY2017 | $747.0M | 10,571.43% |
| FY2016 | $7.0M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $196.0M | — |
| Jun 2026 | −$274.0M | — |
| Mar 2026 | −$29.0M | — |
| Dec 2025 | −$47.0M | — |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| FUL H. B. Fuller Company compare | $197.8M |
| IOSP Innospec Inc. compare | $141.0M |
| KWR Quaker Houghton compare | $97.3M |
| WDFC WD-40 Company compare | $82.3M |
| NGVT Ingevity Corporation compare | $54.0M |
| SCL Stepan Company compare | −$2.7M |
| MTX Minerals Technologies Inc. compare | −$63.0M |
| CC The Chemours Company | −$154.0M |
| STDN Standard Nuclear Inc compare | — |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on CC
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement